Medbright AI Investments Inc MBAIF

MBAI closes LIFE offering for $1.4M

[MarketMakerss]

Having closed its previously announced LIFE offering for gross proceeds of ~$1.4M, MedBright AI (MBAI.c MBAIF) is well financed to continue its business development on the heels of its previously expanded offerings for MedMatrix, its AI-powered data analytics platform.

 

Adding onto its previous adoption, Rejuvenation, a prominent dermatology group and leader in advanced dermatological care, has expanded its already established use of MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis.

 

This is a significant demonstration of both the substantial scalability and the vast addressable market that is open to MedMatrix and, as MBAI continues to execute on this path, it could mean quick multiples from successfully solving even a small percentage of the addressable market.

 

Notably, Rejuvenation's extensive network includes 8 clinics spread across 3 provinces with a highly skilled team comprising of 21 dermatologists, 5 Mohs surgeons, 2 plastic surgeons, and 13 general practitioners specializing in dermatology.

 

Despite having an mcap of only $22M, MBAI has been able to expand to 14 clinics, including a Yale University-Affiliated Clinic, and is strongly positioned to fix the $200 billion healthcare problem of congested waiting rooms.

 

MedMatrix

Focused on the intersection of healthcare and technology to match patient needs with enhanced revenue opportunities, MedBright AI (MBAI.c MBAIF) is the primary shareholder of and is targeting the healthcare waiting room problem with MedMatrix.

 

As detailed in this short introduction video, MedMatrix is an AI-powered data analytics platform and engine that analyzes crucial aspects of healthcare facilities and works alongside healthcare professionals to drastically improve healthcare operations and enhance clinic revenue by 10% at no additional cost to the clinic: https://youtu.be/f3bcx2T_GzQ?si=9CXluAYD43PEDMM9

 

In better aligning physician resources with patient needs, MedMatrix evaluates numerous factors related to a patients background, clinical interaction history and other factors to predict the resource needs for their upcoming visits and optimize provider schedules, without the need for a new platform or additional training.

 

Full News Release: https://www.newswire.ca/news-releases/medbright-ai-investments-inc-announces-life-amp-special-warrant-offering-up-to-approximately-c-2-800-000-897923641.html

 

Posted on Behalf of MedBright AI Investments Inc.